reglab/statecodes huggingface dataset:
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-130 - Salmonellosis, nontyphoidal; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 130.
The specific control measures for salmonellosis,
				  nontyphoidal (infectious agent: Salmonella species) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a three (3) day
				food and drink consumption history prior to symptom onset with emphasis on
				exposure to inadequately cooked poultry and poultry products, uncooked or
				lightly cooked eggs or egg products, and unpasteurized milk products.
(C) Determine if meal companions are
				additional cases.
(D) If a
				commercial food product or restaurant is suspected, active surveillance shall
				be conducted to identify additional cases.
(E) Determine if the case is part of an
				outbreak.
(F) Determine if the case
				is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
Medical evaluation, including adequate laboratory examination
				  of feces of contacts, should be limited to food employees, daycare workers,
				  health care workers, or other situations where outbreaks may occur.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-131 - Shigellosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 131.
The specific control measures for shigellosis (infectious
				  agent: Shigella species) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a five (5) day food and drink
				consumption history.
(C) Determine
				if the case is part of an outbreak.
(D) Determine if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(E) Determine if the case is a contact of a
				food employee serving a highly susceptible population.
(F) Identify household members and close
				contacts who are food employees, health care workers, or daycare workers. Any
				such identified contact shall have one (1) stool culture, whether asymptomatic
				or not, to identify other infected individuals.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-132 - Smallpox; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 132.
The control measures for smallpox (infectious agent: Variola
				  virus) are as follows:
(1) An
				investigation by the department in conjunction with the local health officer
				shall be performed immediately to determine the possible sources of infection
				and the extent of the outbreak and include the following:
(A) A history of past and recent smallpox
				vaccinations.
(B) A history of
				varicella and shingles vaccinations.
(C) A history of varicella or herpes
				zoster.
(D) A medical
				history.
(E) A collection of
				appropriate laboratory specimens.
(F) A recent travel history.
A complete list of contacts shall be generated and traced.
				  Contacts are defined as all individuals in the household, all individuals with
				  a history of habitual close contact, and all individuals directly exposed to
				  the patient.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-133 - Staphylococcus aureus, vancomycin resistant level &gt;= 8 g/mL, or severe Staphylococcus aureus in a previously healthy person; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 133.
The specific control measures for Staphylococcus aureus,
				  vancomycin resistant level >= 8 µg/mL, or severe Staphylococcus aureus
				  in a previously healthy person are as follows:
(1) An investigation by the department in
				collaboration with the local health officer shall be performed within
				seventy-two (72) hours to:
(A) verify
				resistant or intermediate resistant culture isolate to vancomycin;
				and
(B) provide antibiotic
				susceptibility results for severe Staphylococcus aureus infection in a
				previously healthy person that results in death or admission to an intensive
				care unit.
For purposes of this section, "previously healthy person"
				  means a person who has not been hospitalized or had surgery, dialysis, or
				  residency in a long term care facility in the past year and did not have an
				  indwelling catheter or percutaneous medical device at the time of culture. The
				  investigation includes laboratory verification of resistance. Abrupt increases
				  in the prevalence of the disease in the community shall be investigated for a
				  common source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-134 - Streptococcus pneumoniae, invasive disease; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 134.
The specific control measures for Streptococcus pneumoniae,
				  invasive disease, are as follows:
(1)
				An investigation of cases and the source of infection shall be as follows:
(A) An investigation by a department field
				representative, in collaboration with the local health officer, shall:
(i) be performed within seventy-two (72)
				hours for cases less than five (5) years of age; and
(ii) include:
(AA) a complete pneumococcal vaccine
				immunization history;
(BB) drug
				resistance pattern of isolate; and
(CC) a history of chronic underlying medical
				conditions, asplenia, or immunosuppression.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-135 - Streptococcal invasive disease, group A and streptococcal toxic shock syndrome; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 135.
The specific control measures for streptococcal invasive
				  disease (see section 46 of this rule for definition of invasive disease) and
				  toxic shock syndrome (infectious agent: Streptococcus pyogenes) are as
				  follows:
(1) An investigation by the
				local health officer shall be performed within seventy-two (72) hours to
				ascertain that the case meets the case definition for group A streptococcal
				invasive disease or streptococcal toxic shock syndrome as follows:
(A) The Centers for Disease Control and
				Prevention (CDC) case definition for an invasive group A streptococcal (GAS)
				states that the GAS must be isolated from a normally sterile site, such as
				blood, cerebrospinal fluid (CSF), pleural fluid, peritoneal fluid, surgical
				aspirate, bone, joint fluid, or internal body site (e.g., lymph node, brain,
				muscle, if surgically removed). An exception to the sterile site case
				definition would be a GAS isolated from a wound culture and accompanied by
				necrotizing fasciitis or streptococcal toxic shock syndrome (STSS).
(B) The CDC case definition for STSS is the
				isolation of GAS along with the following clinical manifestations:
(i) Hypotension defined by a systolic blood
				pressure less than or equal to ninety (90) mm Hg for adults or less than the
				fifth percentile by age for children less than sixteen (16) years of
				age.
(ii) Multi-organ involvement
				characterized by two (2) or more of the following:
(AA) Renal impairment.
(BB) Coagulopathy.
(CC) Liver involvement.
(DD) Acute respiratory distress.
(EE) Rash.
(FF) Soft-tissue necrosis.
Identify if the case had a recent case of varicella or
				  underlying chronic disease. Be alert for outbreaks defined as two (2) or more
				  cases occurring close together in place and time.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-136 - Syphilis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 136.
The specific control measures for syphilis (infectious
				  agent: Treponema pallidum) are as follows:
(1) An investigation by a disease
				intervention specialist, in cooperation with the local health officer, shall be
				performed within seventy-two (72) hours. The investigation shall be focused on
				identifying sexual partners who were at risk for transmitting to, or
				contracting the infection from, the case. Cases and contacts shall be fully
				evaluated (including pregnancy status of females) and treated as recommended in
				the Sexually Transmitted Diseases Treatment Guidelines, 2010, Morbidity and
				Mortality Weekly Report, December 17, 2010, Volume 59, No. RR-12.
(2) For hospitalized patients, standard
				precautions are required. For others, the infected persons shall refrain from
				sexual activities involving exchange of body fluids until:
(A) their lesions clear; and
(B) they have been on appropriate antibiotic
				therapy for at least twenty-four (24) hours.
Treated persons shall also avoid sexual activities involving
				  exchange of body fluids with untreated partners to avoid reinfection.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-137 - Taeniasis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 137.
The specific control measures for taeniasis (infectious
				  agent: Taenia solium) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours. Collect food
				consumption history, concentrating on meats, specifically undercooked pork, for
				eight (8) to forty-five (45) days prior to the onset of symptoms. A travel
				history may provide leads to unusual foods or source of foods with increased
				risk. Identify and interview family members and others that the case normally
				shares meals with to identify additional cases of taeniasis and possibly
				cysticercosis.
(2) Standard
				precautions are required.
(3)
				Concurrent disinfection is not required.
(4) Quarantine is not required.
(5) Immunization is not available. Protection
				of contacts is not applicable.
(6)
				Case definition is established by the department.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-138 - Tetanus; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 138.
The specific control measures for tetanus (infectious agent:
				  Clostridium tetani) are as follows:
(1) An investigation by a department field
				representative, in cooperation with the local health officer, shall:
(A) be performed within seventy-two (72)
				hours; and
(B) include:
(i) a complete tetanus toxoid immunization
				history;
(ii) the wound location
				and circumstance of injury or possible source of infection;
(iii) treatment information; and
(iv) the outcome of the case.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-139 - Toxic shock syndrome; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 139.
The specific control measures for toxic shock syndrome
				  (staphylococcal) are as follows:
(1)
				An investigation by the local health officer shall be performed within
				seventy-two (72) hours for the following:
(A)
				Case ascertainment.
(B) Clinical
				findings.
(C) Culture
				results.
(D) Suspected source of
				infection.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-140 - Trichinosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 140.
The specific control measures for trichinosis (infectious
				  agent: Trichinella spiralis) are as follows:
(1) An investigation by the local health
				officer shall be performed within seventy-two (72) hours. Collect food
				consumption history, concentrating on meats, for eight (8) to forty-five (45)
				days prior to the onset of symptoms. A travel history may provide leads to
				unusual foods or source of foods with increased risk. Identify and interview
				family members and others that the case normally shares meals with to identify
				additional cases.
(2) Standard
				precautions are required.
(3)
				Concurrent disinfection is not required.
(4) Quarantine is not required.
(5) Immunization is not available. Protection
				of contacts is not applicable.
(6)
				The Centers for Disease Control and Prevention and the Council of State and
				Territorial Epidemiologists set the standard clinical and laboratory case
				definition.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-141 - Tuberculosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 141.
The specific control measures for tuberculosis disease
				  (called tuberculosis or TB) (infectious agent: Mycobacterium tuberculosis) are
				  as follows:
(1) All suspect and
				confirmed cases of pulmonary, extrapulmonary, and miliary tuberculosis must be
				reported to the local health officer or the department. All suspect and
				confirmed cases of multiple drug-resistant tuberculosis require consultation
				with the department for appropriate and adequate treatment.
(2) An investigation by the local health
				officer shall be performed immediately and shall include case management. The
				local health officer shall request laboratory, radiological, and other studies
				as required for case ascertainment and to determine if the suspect case should
				be isolated as described in subdivision (3). For confirmed and suspected cases
				of pulmonary, laryngeal, or pleural tuberculosis, a contact investigation shall
				be performed, identifying both high and medium priority contacts.
				Prioritization of contacts is to be assigned in accordance with Guidelines for
				the Investigation of Contacts of Persons with Infectious Tuberculosis.
				Recommendations from the National Tuberculosis Controllers Association and CDC.
				MMWR; December 16, 2005; Vol. 54; No. RR-15. Priority is based on the
				likelihood of infection and the potential hazards to the individual contact
				infected as follows:
(A) Prioritization of
				contacts exposed to persons with acid-fast bacilli (AFB) sputum positive or
				cavitary tuberculosis cases is as follows:
(i)
				High-priority contacts include the following:
(AA) Household contacts.
(BB) Children less than five (5) years of
				age.
(CC) Persons with medical risk
				factors, including HIV.
(DD)
				Persons exposed during medical procedures.
(EE) Persons exposed in a congregate
				setting.
(FF) Persons that exceed
				duration of environment limits as determined on a case-by-case basis by the
				department.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-142 - Tularemia; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 142.
The specific control measures for tularemia (infectious
				  agent: Francisella tularensis) are as follows:
(1) An investigation by the local health
				officer shall be performed immediately for the following:
(A) Case ascertainment.
(B) Identification of infection
				source.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-143 - Typhoid and paratyphoid fever; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 143.
The specific control measures for typhoid and paratyphoid
				  fever (infectious agents: Salmonella serotype Typhi, Paratyphi A, Paratyphi B
				  (tartrate negative), or Paratyphi C) are as follows:
(1) An investigation by the local health
				officer shall meet the following conditions:
(A) Be performed immediately.
(B) Include a three (3) week history of the
				following prior to symptom onset:
(i) Food and
				drink consumption.
(ii) Domestic
				and international travel.
(C) Identify unreported cases or
				carriers.
(D) Identify any
				potentially contaminated:
(i) food;
(ii) water;
(iii) milk; and
(iv) shellfish.
(E) If the case traveled three (3) weeks
				prior to onset, all members of travel groups in which a case has occurred shall
				be interviewed for probable source of infection and additional cases.
(F) Determine if the case is part of an
				outbreak.
(G) Determine if the case
				is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(H) Determine if the case is a contact of a
				food employee serving a highly susceptible population.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-144 - Typhus, endemic (fleaborne); specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 144.
The specific control measures for endemic typhus (infectious
				  agent: Rickettsia species) are as follows:
(1) An environmental investigation for the
				presence of rodents or squirrels, or both, around the premises of the home of
				the patient shall be done within seventy-two (72) hours. Provide guidance on:
(A) the use of insecticides to kill rodent
				fleas; and
(B) rodent exclusion
				from the premises or home.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-145 - Varicella (chickenpox); specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 145.
The specific control measures for varicella (chickenpox)
				  (infectious agent: Varicella-zoster virus) are as follows:
(1) Every case of primary varicella disease
				shall be reported to the local health officer within seventy-two (72) hours.
				For all cases of primary varicella disease, an investigation shall be performed
				to ascertain the following:
(A) An
				immunization history.
(B) Primary
				varicella disease history.
(C) A
				history of underlying chronic or immunosuppressive disease.
(D) Disease severity and
				hospitalization.
(E)
				Characteristics of the rash, reported as the following:
(i) Crusts.
(ii) Macules (flat spots).
(iii) Papules (solid bumps).
(iv) Vesicles (fluid-filled
				blisters).
(F) Location
				of the rash, reported as the following:
(i)
				Generalized.
(ii) Focal.
(iii) Unknown.
(G) Name and contact information for employer
				or school/daycare attended.
(H)
				Identification of any known case of varicella with an epidemiologic
				link.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-146 - Vibriosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 146.
The specific control measures for vibriosis (non-cholera)
				  (infectious agent: Vibrio species other than toxigenic Vibrio cholerae 01 or
				  0139, Grimontia hollisae (Vibrio hollisae), Photobacterium damselae (Vibrio
				  damsela)) are as follows:
(1) An
				investigation by the local health officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a three (3) week
				history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Wounds.
(iii) Domestic and international
				travel.
(C) Every case
				should be investigated for an actual or probable source. The investigation
				shall focus on identifying the following:
(i)
				Unreported cases.
(ii)
				Carriers.
(iii) Contaminated:
(AA) food;
(BB) water;
(CC) milk; and
(DD) shellfish.
(D) If the case traveled three (3)
				weeks prior to onset, all members of travel groups in which a case has occurred
				shall be interviewed for probable source of infection and additional
				cases.
(E) Determine if the case is
				part of an outbreak.
(F) Determine
				if the case is a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-147 - Yellow fever; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 147.
The specific control measures for yellow fever (infectious
				  agent: yellow fever virus) are as follows:
(1) An investigation by a department field
				representative, in cooperation with the local health officer, shall:
(A) be performed immediately; and
(B) include:
(i) laboratory confirmation;
(ii) immunization status; and
(iii) a history of foreign travel in three
				(3) to six (6) days prior to the onset.
Identify traveling companions who may also have been
				  exposed.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-148 - Yersiniosis; specific control measures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 148.
The specific control measures for yersiniosis (infectious
				  agents: Yersinia enterocolitica or Yersinia pseudotuberculosis) are as
				  follows:
(1) An investigation by the
				local health officer shall meet the following conditions:
(A) Be performed within seventy-two (72)
				hours.
(B) Include a seven (7) day
				history of the following prior to symptom onset:
(i) Food and drink consumption.
(ii) Water exposure.
(iii) Animal exposure.
(C) Determine if the affected individual is
				a:
(i) food employee;
(ii) daycare worker;
(iii) health care worker; or
(iv) daycare attendee, a school attendee, or
				anyone who lives at a residential institution.
(D) Determine if meal companions are
				additional cases.
(E) If a
				commercial food product or restaurant is suspected, conduct active surveillance
				for additional cases.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-1 - "Bedding" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 1.
"Bedding" means bedding that has been used for laboratory
				  animals.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-2 - "Carcasses, body parts, blood and body fluids, and bedding of laboratory animals" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 2.
"Carcasses, body parts, blood and body fluids, and bedding
				  of laboratory animals" means carcasses, body parts, blood and body fluids in
				  liquid or semiliquid form, and bedding of animals that have been intentionally
				  or are suspected of having been exposed to pathogens in:
(1) research;
(2) production of biologicals;
(3) the in vivo testing of pharmaceuticals;
				or
(4) other
				procedures.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-3 - "Container" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 3.
"Container" means any portable device or material in which
				  infectious waste is:
(1)
				stored;
(2) transported;
(3) treated;
(4) disposed of; or
(5) otherwise handled.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-4 - "Contaminated sharp" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 4.
"Contaminated sharp" means an object that is capable of
				  cutting or penetrating the skin and has been in contact with blood or body
				  fluids. The term includes any of the following:
(1) Hypodermic or suture needle.
(2) Syringe.
(3) Scalpel blade.
(4) Pipette.
(5) Lancet.
(6) Broken glass.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-5 - "Communicable disease" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC
				  16-41-2-1
Sec. 5.
"Communicable disease" means a communicable disease as
				  defined by rule under IC
				  16-41-2-1.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-5.5 - "Department" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 5.5.
"Department" means the Indiana department of health.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-6 - "Emergency medical services provider" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-31-3
Sec. 6.
"Emergency medical services provider" means a person
				  certified under IC 16-31-3.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-7 - "Facility" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-21-2; IC 16-28-1; IC 16-41-12; IC
				  16-41-16
Sec. 7.
"Facility" means any of the following places where
				  infectious waste activity occurs:
(1)
				Hospital.
(2) Ambulatory surgical
				center as defined in IC 16-21-2.
(3) Medical/diagnostic laboratory.
(4) Blood center as defined in IC
				16-41-12.
(5) Pharmaceutical
				company.
(6) Academic research
				laboratory company.
(7) Industrial
				research laboratory.
(8) Health
				facility as defined in IC 16-28-1.
(9) Office and mobile units of a health care
				provider.
(10) Diet or health care
				clinic.
(11) Office of a
				veterinarian.
(12) Veterinary
				hospital.
(13) Emergency medical
				services provider.
(14)
				Mortuary.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-8 - "Health care provider" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC
				  16-18-2-163;
				  IC 16-41-16
Sec. 8.
"Health care provider" means a person employed as, or by, or
				  receiving training from, a provider as defined in IC
				  16-18-2-163,
				  or by a laboratory, blood center, state institution, or any other facility
				  where the person is likely to have direct contact with blood or body
				  fluids.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-9 - "Infectious waste activity" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 9.
"Infectious waste activity" means the:
(1) generation;
(2) collection;
(3) storage;
(4) transportation;
(5) treatment; or
(6) disposal of infectious waste; as defined
				in this rule.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-10 - "Infectious waste" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 10.
(a)
				"Infectious waste", except as provided in subsection (b), means waste that
				epidemiologic evidence indicates is capable of transmitting a dangerous
				communicable disease. The term includes, but is not limited to, the following:
(1) Contaminated sharps or contaminated
				objects that could potentially become contaminated sharps.
(2) Infectious biological cultures,
				infectious associated biologicals, and infectious agent stock.
(3) Pathological waste.
(4) Blood and blood products in liquid and
				semiliquid form.
(5) Carcasses,
				body parts, blood and body fluids in liquid and semiliquid form, and bedding of
				laboratory animals.
(6) Other waste
				that has been intermingled with infectious waste.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-11 - "Mortuary" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16; IC
				  25-15-2-15
Sec. 11.
"Mortuary" means a funeral home as defined in IC
				  25-15-2-15.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-12 - "Pathological waste" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 12.
"Pathological waste" means:
(1) tissues;
(2) organs;
(3) body parts; and
(4) blood or body fluids in liquid or
				semiliquid form of humans; that are removed during surgery, biopsy, or autopsy.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-13 - "Person" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 13.
"Person" means any:
(1) individual;
(2) facility;
(3) partnership;
(4) copartnership;
(5) firm;
(6) company;
(7) association;
(8) joint-stock company;
(9) corporation;
(10) governmental entity; or
(11) agent.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-14 - "Secured area" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 14.
"Secured area" means an area that is designed and maintained
				  to prevent the entry of unauthorized persons.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-15 - "Semiliquid blood and blood products" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 15.
"Semiliquid blood and blood products" means blood and blood
				  products that have intermediate fluid properties and are capable of flowing in
				  a manner similar to a liquid.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-17 - "Storage" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 17.
"Storage" means the containment of infectious waste in such
				  a manner as not to constitute:
(1)
				collection;
(2)
				treatment;
(3) transport;
				or
(4) disposal.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-18 - "Veterinarian" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 18.
"Veterinarian" means a person authorized to practice
				  veterinary medicine under IC 15-5-1.1
[IC 15-5 was repealed by P.L.
				  2-2008, SECTION 83, effective July 1, 2008.]
.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-19 - "Waste" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 19.
"Waste" means any solid, liquid, or semiliquid material
				  that:
(1) is discarded or being
				accumulated prior to being discarded; or
(2) has served its natural, biological,
				medical, or intended purpose and is generally discarded and not
				reused.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-20 - "Waste handlers" defined

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 20.
"Waste handlers" means any person who handles infectious
				  waste.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-21 - Applicability of standards

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-11
Sec. 21.
(a) This
				rule applies, without regard to quantity, to defined facilities and persons
				involved in infectious waste activity.
(b) This rule represents minimum standards,
				and persons may utilize more stringent standards.
(c) All written policies required under this
				rule shall, at a minimum, comply with the requirements of IC 16-41-11.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-22 - Appropriate containment and labeling; effective treatment, transport, or disposal

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 22.
For purposes of IC 16-41-16 and this rule, the generator of
				  infectious waste is responsible for the appropriate containment, appropriate
				  labeling, effective treatment, transport, and disposal of infectious waste as
				  required by this rule. A person may provide services to the generator of
				  infectious waste, including the appropriate containment, appropriate labeling,
				  effective treatment, transport, or disposal of infectious waste. Both the
				  generator of infectious waste and the person providing services to the
				  generator of infectious waste are responsible for complying with the
				  requirements set forth in this rule.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-23 - Written policies, procedures

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC
				  16-41-16-9
Sec. 23.
All persons and facilities subject to this rule
				  shall:
(1) have a written policy and
				procedures that, at a minimum, contain:
(A)
				the requirements contained in this rule; and
(B) the sanctions, including discipline and
				dismissal of persons, if warranted, for failure to follow the requirements set
				forth in this rule;
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-24 - Containment

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 24.
(a) All
				persons and facilities subject to this rule shall ensure that infectious waste
				is at all times contained in a manner that will reasonably protect waste
				handlers and the public from contracting dangerous communicable disease that
				may result from exposure to the infectious waste.
(b) All persons and facilities subject to
				this rule shall place contaminated sharps or contaminated objects that could
				potentially become contaminated sharps, infectious biological cultures,
				infectious associated biologicals, and infectious agent stock in containers
				that are:
(1) leak proof, rigid,
				puncture-resistant;
(2) tightly
				sealed to prevent expulsion;
(3)
				labeled with the biohazard symbol; and
(4) effectively treated in accordance with
				this rule prior to being stored in an unsecured area and sent for final
				disposal.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-25 - Storage

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 25.
If infectious waste is stored prior to final disposal, all
				  persons subject to this rule shall:
(1) store infectious waste in a secure area
				that:
(A) is locked or otherwise secured to
				eliminate access by or exposure to the general public;
(B) affords protection from adverse
				environmental conditions and vermin; and
(C) has a prominently displayed biohazard
				symbol;
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-26 - Treatment

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 26.
(a) All
				persons and facilities subject to this rule shall either effectively treat
				infectious waste in accordance with this rule or transport infectious waste
				off-site for effective treatment in accordance with this rule.
(b) A treatment is effective if it reduces
				the pathogenic qualities of infectious waste for safe handling, is designed for
				the specific infectious waste involved, and is carried out in a manner
				consistent with this rule. Effective treatment may include:
(1) incineration;
(2) steam sterilization;
(3) chemical disinfection;
(4) thermal inactivation;
(5) irradiation; or
(6) discharge in a sanitary sewer or septic
				system that is properly installed and operating in accordance with state and
				local laws.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-27 - Protection in transport

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 27.
All persons and facilities subject to this rule
				  shall:
(1) transport infectious waste
				in a manner that reasonably protects waste handlers and the public from
				contracting dangerous communicable disease; and
(2) effectively treat infectious waste in
				accordance with this rule before it is compacted.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-28 - Transporting off-site

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC 16-41-16
Sec. 28.
(a) All
				persons and facilities subject to this rule who are transporting infectious
				waste off-site, whether effectively treated or not, shall:
(1) mark containers of infectious waste with
				a label that states the name, address, and telephone number of the generating
				facility and treatment facility, if applicable; and
(2) provide a form that contains:
(A) the name, address, and telephone number
				of the generating facility and treatment facility, if applicable;
(B) a brief description of the waste and the
				method of effective treatment; and
(C) the signature of a responsible
				person.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 3 - Infectious Waste › Section 3-29 - Penalties for violation

Current through July 10, 2024
Authority: IC
				  16-19-3-4;
				  IC
				  16-41-16-8
Affected: IC
				  16-41-16-10
Sec. 29.
Penalties for violation of this rule are set forth in IC
				  16-41-16-10.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-0.5 - Applicability of definitions

Current through July 10, 2024
Authority: IC 16-41-11-9
Affected: IC 16-41-11
Sec. 0.5.
The definitions in this rule apply throughout this rule.
				  Additionally, the definitions of any other terms contained in the Indiana
				  occupational safety and health administration's bloodborne pathogens standards
				  (as found in
				  29 CFR
				  1910.1030 ) are incorporated by
				  reference.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1 - "Blood" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 1.
"Blood" means human blood, human blood components, and
				  products made from human blood.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1.1 - "Bloodborne pathogens" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 1.1.
"Bloodborne pathogens" means pathogenic microorganisms that
				  are present in human blood and can cause disease in humans. These pathogens
				  include, but are not limited to, HBV, HCV, and HIV.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1.2 - "Contaminated" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 1.2.
"Contaminated" means the presence or the reasonably
				  anticipated presence of blood or other potentially infectious materials on an
				  item or surface.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1.3 - "Contaminated laundry" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 1.3.
"Contaminated laundry" means laundry which has been soiled
				  with blood or other potentially infectious materials or laundry which may
				  contain sharps.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1.4 - "Covered individual" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC
				  16-41-11-4
Sec. 1.4.
"Covered individual" means any individual covered by IC
				  16-41-11-4
				  whose professional, employment, training, or volunteer activities or duties
				  include any reasonably anticipated skin, eye, mucous membrane, or parenteral
				  contact with blood or other potentially infectious materials.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-1.5 - "Decontamination" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 1.5.
"Decontamination" means the use of physical or chemical
				  means to remove, inactivate, or destroy bloodborne pathogens on a surface or
				  item which does not require sterilization to the point where they are no longer
				  capable of transmitting infectious particles and the surface or item is
				  rendered safe for handling, use, or disposal.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-2 - "Department" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 2.
"Department" means the Indiana department of health.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-2.1 - "Employee" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11; IC
				  22-8-1.1-1
Sec. 2.1.
"Employee" has the meaning set forth in IC
				  22-8-1.1-1.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-3 - "Employer" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11; IC
				  22-8-1.1-1
Sec. 3.
"Employer" has the meaning set forth in IC
				  22-8-1.1-1.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-3.1 - "ERP" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 3.1.
"ERP" means expert review panel, as defined in section 8.1
				  of this rule.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-4 - "Facility" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 4.
"Facility" means a building or location where an individual
				  can be reasonably anticipated in the course of performing his or her
				  professional, employment, training, or volunteer activities or duties to have
				  skin, eye, mucous membrane, or parenteral contact with potentially infectious
				  materials.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-4.1 - "HBeAg" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 4.1.
"HBeAg" means the presence of hepatitis B e antigen in human
				  blood as an indicator of high infectivity for hepatitis B virus.
Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 4 - Universal Precautions › Section 4-4.2 - "HBsAg" defined

Current through July 10, 2024
Authority: IC
				  16-41-11-9
Affected: IC 16-41-11
Sec. 4.2.
"HBsAg" means the presence of hepatitis B surface antigens
				  in human blood as an indicator of infectivity for hepatitis B virus.